A 15-year review of esophagectomy for carcinoma of the esophagus and cardia

K. W. Millikan, J. Silverstein, V. Hart, K. Blair, S. Bines, J. Roberts and A. Doolas
Department of General Surgery, Rush Medical College, Chicago, Ill., USA.

OBJECTIVE: To evaluate the effect of surgical approach and adjuvant therapy on patients with carcinoma of the esophagus and/or cardia. DESIGN: Retrospective analysis of 157 consecutive patients who underwent esophagectomy. SETTING: A private university medical center and its affiliated community hospital. PATIENTS: One hundred twenty men and 37 women (mean age, 61.7 years) with carcinoma of the esophagus and/or cardia that was surgically treated between 1978 and 1993. INTERVENTIONS: Three approaches were used for resection: Transhiatal esophagectomy (THE) (n = 67), transthoracic esophagectomy (TTE) (n = 71), and abdominal-only esophagectomy (AOE) (n = 19). Sixty-five patients received adjuvant radiotherapy and chemotherapy. MAIN OUTCOME MEASURES: Surgical mortality, morbidity, and survival and the effect of adjuvant therapy. RESULTS: The overall surgical mortality rate was 7.6%: 12.7% with the TTE, 4.5% with the THE, and 0% with the AOE approach. A significantly increased incidence of adult respiratory distress syndrome (P < .001) and empyema (P < .001) was seen with the TTE approach. The average intraoperative blood loss (P = .08) and the median intensive care unit stay (P = .26) and hospital stay (P = .40) were decreased with the THE and AOE approaches when compared with the TTE approach without significance. The overall median survival time was 17 months, with a 5-year survival rate of 21%. There was no significant difference in survival by pathologic stage between approaches. The addition of adjuvant therapy did not affect the overall median survival time or the 5-year survival rate. Node-positive patients did benefit from adjuvant radiotherapy and chemotherapy, with increased median survival times from 7 to 15 months and a 5-year survival rate from 0% to 15% (P = .01). CONCLUSIONS: The THE and AOE approaches have fewer early complications than does TTE. Both THE and TTE have equal long-term survival rates. Adjuvant therapy provides increased survival to node-positive patients with carcinoma of the esophagus and/or cardia.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Feasibility and Outcomes of an Early Extubation Policy After Esophagectomy
Lanuti et al.
Ann. Thorac. Surg. 2006;82:2037-2041.
ABSTRACT | FULL TEXT  

The Influence of Technical Complications on Postoperative Outcome and Survival After Esophagectomy
Ferri et al.
Ann. Surg. Oncol. 2006;13:557-564.
ABSTRACT | FULL TEXT  

Risk Analysis in Resection of Thoracic Esophageal Cancer in the Era of Endoscopic Surgery.
Shiraishi et al.
Ann. Thorac. Surg. 2006;81:1083-1089.
ABSTRACT | FULL TEXT  

Low-Dose Steroid Therapy at an Early Phase of Postoperative Acute Respiratory Distress Syndrome
Lee et al.
Ann. Thorac. Surg. 2005;79:405-410.
ABSTRACT | FULL TEXT  

Effect of prostaglandin E1 on inflammatory responses and gas exchange in patients undergoing surgery for oesophageal cancer
Nakazawa et al.
Br J Anaesth 2004;93:199-203.
ABSTRACT | FULL TEXT  

Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus
Polee et al.
Ann Oncol 2003;14:1253-1257.
ABSTRACT | FULL TEXT  

Lung injury after thoracotomy
Baudouin
Br J Anaesth 2003;91:132-142.
FULL TEXT  

Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy. Results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital
Chandrashekar et al.
Br J Anaesth 2003;90:474-479.
ABSTRACT | FULL TEXT  

Pulmonary complications after esophagectomy
Avendano et al.
Ann. Thorac. Surg. 2002;73:922-926.
ABSTRACT | FULL TEXT  

Multimodality therapy for resectable cancer of the thoracic esophagus
Entwistle and Goldberg
Ann. Thorac. Surg. 2002;73:1009-1015.
ABSTRACT | FULL TEXT  

Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis
Hulscher et al.
Ann. Thorac. Surg. 2001;72:306-313.
ABSTRACT | FULL TEXT  

Peri-operative risk factors for acute lung injury after elective oesophagectomy{{dagger}}
Tandon et al.
Br J Anaesth 2001;86:633-638.
ABSTRACT | FULL TEXT  

Minimally invasive esophagectomy
Luketich et al.
Ann. Thorac. Surg. 2000;70:906-911.
ABSTRACT | FULL TEXT  

Comparison of Minimally Invasive Esophagectomy With Transthoracic and Transhiatal Esophagectomy
Nguyen et al.
Arch Surg 2000;135:920-925.
ABSTRACT | FULL TEXT  

Surgical Management of Esophageal Carcinoma
Reed
The Oncologist 1999;4:95-105.
ABSTRACT | FULL TEXT  

Prognostic Value of Immunohistochemically Identifiable Tumor Cells in Lymph Nodes of Patients with Completely Resected Esophageal Cancer
Izbicki et al.
NEJM 1997;337:1188-1194.
ABSTRACT | FULL TEXT  

ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA
Ellis et al.
J. Thorac. Cardiovasc. Surg. 1997;113:836-848.
ABSTRACT | FULL TEXT  

THORACOSCOPIC EN BLOC TOTAL ESOPHAGECTOMY WITH RADICAL MEDIASTINAL LYMPHADENECTOMY
Akaishi et al.
J. Thorac. Cardiovasc. Surg. 1996;112:1533-1541.
ABSTRACT | FULL TEXT